Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

IRIX vs DBVT vs ALKS vs LASE vs PRGO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
IRIX
IRIDEX Corporation

Medical - Devices

HealthcareNASDAQ • US
Market Cap$18M
5Y Perf.-57.3%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1690.08T
5Y Perf.+11.5%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.83B
5Y Perf.+56.7%
LASE
Laser Photonics Corporation

Industrial - Machinery

IndustrialsNASDAQ • US
Market Cap$19M
5Y Perf.-66.2%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.62B
5Y Perf.-67.2%

IRIX vs DBVT vs ALKS vs LASE vs PRGO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
IRIX logoIRIX
DBVT logoDBVT
ALKS logoALKS
LASE logoLASE
PRGO logoPRGO
IndustryMedical - DevicesBiotechnologyBiotechnologyIndustrial - MachineryDrug Manufacturers - Specialty & Generic
Market Cap$18M$1690.08T$5.83B$19M$1.62B
Revenue (TTM)$51M$0.00$1.56B$7M$4.18B
Net Income (TTM)$-5M$-168M$153M$-8M$-1.82B
Gross Margin38.0%65.4%31.1%34.2%
Operating Margin-6.0%12.3%-126.5%-4.1%
Forward P/E24.5x5.5x
Total Debt$5M$22M$70M$5M$3.97B
Cash & Equiv.$2M$194M$1.12B$534K$532M

IRIX vs DBVT vs ALKS vs LASE vs PRGOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

IRIX
DBVT
ALKS
LASE
PRGO
StockSep 22May 26Return
IRIDEX Corporation (IRIX)10042.7-57.3%
DBV Technologies S.… (DBVT)100111.5+11.5%
Alkermes plc (ALKS)100156.7+56.7%
Laser Photonics Cor… (LASE)10033.8-66.2%
Perrigo Company plc (PRGO)10032.8-67.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: IRIX vs DBVT vs ALKS vs LASE vs PRGO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ALKS and PRGO are tied at the top with 3 categories each (5-stock set) — the right choice depends on your priorities. Perrigo Company plc is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. DBVT also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
IRIX
IRIDEX Corporation
The Healthcare Pick

IRIX lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
DBVT
DBV Technologies S.A.
The Momentum Pick

DBVT ranks third and is worth considering specifically for momentum.

  • +100.5% vs LASE's -69.6%
Best for: momentum
ALKS
Alkermes plc
The Growth Play

ALKS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth -5.2%, EPS growth -34.1%, 3Y rev CAGR 9.9%
  • -12.0% 10Y total return vs LASE's -66.2%
  • Lower volatility, beta 1.00, Low D/E 3.8%, current ratio 3.55x
  • Beta 1.00, current ratio 3.55x
Best for: growth exposure and long-term compounding
LASE
Laser Photonics Corporation
The Industrials Pick

Among these 5 stocks, LASE doesn't own a clear edge in any measured category.

Best for: industrials exposure
PRGO
Perrigo Company plc
The Income Pick

PRGO is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 10 yrs, beta 1.21, yield 9.8%
  • -2.8% revenue growth vs DBVT's -100.0%
  • Better valuation composite
  • 9.8% yield; 10-year raise streak; the other 4 pay no meaningful dividend
Best for: income & stability
See the full category breakdown
CategoryWinnerWhy
GrowthPRGO logoPRGO-2.8% revenue growth vs DBVT's -100.0%
ValuePRGO logoPRGOBetter valuation composite
Quality / MarginsALKS logoALKS9.8% margin vs LASE's -105.4%
Stability / SafetyALKS logoALKSBeta 1.00 vs LASE's 1.81, lower leverage
DividendsPRGO logoPRGO9.8% yield; 10-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)DBVT logoDBVT+100.5% vs LASE's -69.6%
Efficiency (ROA)ALKS logoALKS5.4% ROA vs DBVT's -89.0%

IRIX vs DBVT vs ALKS vs LASE vs PRGO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

IRIXIRIDEX Corporation
FY 2024
Retina
57.2%$28M
Cyclo G Six
26.1%$13M
Product and Service, Other
16.7%$8M
DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
LASELaser Photonics Corporation

Segment breakdown not available.

PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B

IRIX vs DBVT vs ALKS vs LASE vs PRGO — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALKSLAGGINGLASE

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 4 of 6 comparable metrics.

PRGO and DBVT operate at a comparable scale, with $4.2B and $0 in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to LASE's -105.4%. On growth, LASE holds the edge at +28.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricIRIX logoIRIXIRIDEX CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcLASE logoLASELaser Photonics C…PRGO logoPRGOPerrigo Company p…
RevenueTrailing 12 months$51M$0$1.6B$7M$4.2B
EBITDAEarnings before interest/tax-$2M-$112M$212M-$8M$58M
Net IncomeAfter-tax profit-$5M-$168M$153M-$8M-$1.8B
Free Cash FlowCash after capex-$3M-$151M$392M-$4M$108M
Gross MarginGross profit ÷ Revenue+38.0%+65.4%+31.1%+34.2%
Operating MarginEBIT ÷ Revenue-6.0%+12.3%-126.5%-4.1%
Net MarginNet income ÷ Revenue-10.0%+9.8%-105.4%-43.5%
FCF MarginFCF ÷ Revenue-5.6%+25.1%-58.7%+2.6%
Rev. Growth (YoY)Latest quarter vs prior year+7.8%+28.2%+28.3%-7.2%
EPS Growth (YoY)Latest quarter vs prior year+25.0%+91.5%-4.1%-7.4%-56.4%
ALKS leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 3 of 5 comparable metrics.

On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than ALKS's 17.0x.

MetricIRIX logoIRIXIRIDEX CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcLASE logoLASELaser Photonics C…PRGO logoPRGOPerrigo Company p…
Market CapShares × price$18M$1690.08T$5.8B$19M$1.6B
Enterprise ValueMkt cap + debt − cash$20M$1690.08T$4.8B$24M$5.1B
Trailing P/EPrice ÷ TTM EPS-1.91x-0.75x24.47x-3.97x-1.14x
Forward P/EPrice ÷ next-FY EPS est.5.53x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple17.01x7.43x
Price / SalesMarket cap ÷ Revenue0.36x3.95x5.68x0.38x
Price / BookPrice ÷ Book value/share8.07x0.65x3.25x1.08x0.55x
Price / FCFMarket cap ÷ FCF12.14x11.17x
PRGO leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 8 of 9 comparable metrics.

ALKS delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-184 for LASE. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to IRIX's 2.21x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs LASE's 1/9, reflecting strong financial health.

MetricIRIX logoIRIXIRIDEX CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcLASE logoLASELaser Photonics C…PRGO logoPRGOPerrigo Company p…
ROE (TTM)Return on equity-108.7%-130.2%+8.8%-183.5%-50.7%
ROA (TTM)Return on assets-17.9%-89.0%+5.4%-43.1%-19.8%
ROICReturn on invested capital-129.9%+18.9%-42.1%+3.7%
ROCEReturn on capital employed-48.8%-145.7%+14.2%-45.9%+4.3%
Piotroski ScoreFundamental quality 0–924714
Debt / EquityFinancial leverage2.21x0.13x0.04x0.49x1.35x
Net DebtTotal debt minus cash$2M-$172M-$1.0B$4M$3.4B
Cash & Equiv.Liquid assets$2M$194M$1.1B$533,871$532M
Total DebtShort + long-term debt$5M$22M$70M$5M$4.0B
Interest CoverageEBIT ÷ Interest expense-189.82x32.30x-6.60x-7.20x
ALKS leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — DBVT and ALKS each lead in 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,165 today (with dividends reinvested), compared to $1,377 for IRIX. Over the past 12 months, DBVT leads with a +100.5% total return vs LASE's -69.6%. The 3-year compound annual growth rate (CAGR) favors DBVT at 5.7% vs LASE's -34.4% — a key indicator of consistent wealth creation.

MetricIRIX logoIRIXIRIDEX CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcLASE logoLASELaser Photonics C…PRGO logoPRGOPerrigo Company p…
YTD ReturnYear-to-date-12.0%+3.6%+23.8%-56.3%-13.6%
1-Year ReturnPast 12 months-9.6%+100.5%+15.2%-69.6%-52.0%
3-Year ReturnCumulative with dividends-54.6%+18.1%+13.2%-71.7%-58.1%
5-Year ReturnCumulative with dividends-86.2%-68.3%+61.7%-66.2%-60.3%
10-Year ReturnCumulative with dividends-90.8%-87.1%-12.0%-66.2%-77.7%
CAGR (3Y)Annualised 3-year return-23.2%+5.7%+4.2%-34.4%-25.2%
Evenly matched — DBVT and ALKS each lead in 3 of 6 comparable metrics.

Risk & Volatility

ALKS leads this category, winning 2 of 2 comparable metrics.

ALKS is the less volatile stock with a 1.00 beta — it tends to amplify market swings less than LASE's 1.81 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 95.6% from its 52-week high vs LASE's 12.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricIRIX logoIRIXIRIDEX CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcLASE logoLASELaser Photonics C…PRGO logoPRGOPerrigo Company p…
Beta (5Y)Sensitivity to S&P 5001.16x1.26x1.00x1.81x1.21x
52-Week HighHighest price in past year$1.65$26.18$36.60$6.77$28.44
52-Week LowLowest price in past year$0.87$7.53$25.17$0.38$9.23
% of 52W HighCurrent price vs 52-week peak+62.4%+75.3%+95.6%+12.9%+41.2%
RSI (14)Momentum oscillator 0–10041.647.460.537.553.1
Avg Volume (50D)Average daily shares traded124K252K2.2M1.9M3.3M
ALKS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

PRGO leads this category, winning 1 of 1 comparable metric.

Analyst consensus: DBVT as "Buy", ALKS as "Buy", PRGO as "Hold". Consensus price targets imply 209.1% upside for PRGO (target: $36) vs 31.5% for ALKS (target: $46). PRGO is the only dividend payer here at 9.82% yield — a key consideration for income-focused portfolios.

MetricIRIX logoIRIXIRIDEX CorporationDBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcLASE logoLASELaser Photonics C…PRGO logoPRGOPerrigo Company p…
Analyst RatingConsensus buy/hold/sellBuyBuyHold
Price TargetConsensus 12-month target$46.33$46.00$36.20
# AnalystsCovering analysts152836
Dividend YieldAnnual dividend ÷ price+9.8%
Dividend StreakConsecutive years of raises00210
Dividend / ShareAnnual DPS$1.15
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.5%0.0%0.0%
PRGO leads this category, winning 1 of 1 comparable metric.
Key Takeaway

ALKS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PRGO leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.

Best OverallAlkermes plc (ALKS)Leads 3 of 6 categories
Loading custom metrics...

IRIX vs DBVT vs ALKS vs LASE vs PRGO: Key Questions Answered

9 questions · data-driven answers · updated daily

01

Is IRIX or DBVT or ALKS or LASE or PRGO a better buy right now?

For growth investors, Perrigo Company plc (PRGO) is the stronger pick with -2.

8% revenue growth year-over-year, versus -13. 3% for Laser Photonics Corporation (LASE). Alkermes plc (ALKS) offers the better valuation at 24. 5x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — IRIX or DBVT or ALKS or LASE or PRGO?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +61.

7%, compared to -86. 2% for IRIDEX Corporation (IRIX). Over 10 years, the gap is even starker: ALKS returned -12. 0% versus IRIX's -90. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — IRIX or DBVT or ALKS or LASE or PRGO?

By beta (market sensitivity over 5 years), Alkermes plc (ALKS) is the lower-risk stock at 1.

00β versus Laser Photonics Corporation's 1. 81β — meaning LASE is approximately 82% more volatile than ALKS relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 2% for IRIDEX Corporation — giving it more financial flexibility in a downturn.

04

Which is growing faster — IRIX or DBVT or ALKS or LASE or PRGO?

By revenue growth (latest reported year), Perrigo Company plc (PRGO) is pulling ahead at -2.

8% versus -13. 3% for Laser Photonics Corporation (LASE). On earnings-per-share growth, the picture is similar: Laser Photonics Corporation grew EPS 40. 5% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — IRIX or DBVT or ALKS or LASE or PRGO?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -73. 8% for Laser Photonics Corporation — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -189. 3% for LASE. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is IRIX or DBVT or ALKS or LASE or PRGO more undervalued right now?

Analyst consensus price targets imply the most upside for PRGO: 209.

1% to $36. 20.

07

Which pays a better dividend — IRIX or DBVT or ALKS or LASE or PRGO?

In this comparison, PRGO (9.

8% yield) pays a dividend. IRIX, DBVT, ALKS, LASE do not pay a meaningful dividend and should not be held primarily for income.

08

Is IRIX or DBVT or ALKS or LASE or PRGO better for a retirement portfolio?

For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

21), 9. 8% yield). Laser Photonics Corporation (LASE) carries a higher beta of 1. 81 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PRGO: -77. 7%, LASE: -66. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between IRIX and DBVT and ALKS and LASE and PRGO?

These companies operate in different sectors (IRIX (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and LASE (Industrials) and PRGO (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: IRIX is a small-cap quality compounder stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; LASE is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while IRIX, DBVT, ALKS, LASE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

IRIX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 22%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

LASE

High-Growth Disruptor

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Gross Margin > 18%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.